Tapio Visakorpi

Tampere, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Journal: Oncogene
Published: May 07, 2025

Identification of protein-coding genes associated with metastatic prostate cancer.

Identification of protein-coding genes associated with metastatic prostate cancer.

Journal: Endocrine-related cancer
Published: March 06, 2025

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Journal: Nature communications
Published: June 03, 2024

Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer.

Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer.

Journal: Cancer gene therapy
Published: March 28, 2024

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth.

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth.

Journal: Cell reports
Published: November 12, 2023

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.

Journal: Endocrine-related cancer
Published: April 24, 2023

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.

Journal: Genome medicine
Published: April 13, 2023

Retraction Note: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.

Retraction Note: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.

Journal: Oncogene
Published: October 17, 2022

Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen.

Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen.

Journal: Endocrine-related cancer
Published: October 04, 2022

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment.

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment.

Journal: Heliyon
Published: October 27, 2021

Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients.

Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients.

Journal: Clinical genitourinary cancer
Published: August 16, 2021

miR-32 promotes MYC-driven prostate cancer.

miR-32 promotes MYC-driven prostate cancer.

Journal: Oncogenesis
Published: April 14, 2021
Showing 1-12 of 162

Last Updated: 09/26/2026